drugset / Trial / NCT01863173

Effect of Metoprolol on Thalassemia Cardiomyopathy

NCT01863173

Phase 2/3 Completed 45 enrolled Shiraz University of Medical Sciences
RandomizedParallel-groupQuadruple-blindTreatment

Summary

effect of B blocker was first evaluated in patient with cardiomyopathy not induced by ischemia and idiopathic which as the most common causes of cardiomyopathy. Effect of BB on Thalassemia cardiomyopathy was evaluated in this study

Timeline

Start
2012-01
Primary completion
2012-05
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metoprolol Other / unclassified

Indications